• Early Development

    Critical success factors such as reimbursement and access are increasingly influencing manufacturers' early stage clinical research processes. More

  • Later Development

    Take a strategic look at how preliminary clinical trial results address the unmet need in the market and how this may influence reimbursement and access at launch. More

  • 12 to 24 Months Prior to Launch

    Choose a partner who understands all stakeholders, has the experience to anticipate what challenges may lay ahead - and the insight to develop appropriate strategies to overcome them. More

  • Launch

    Even when pre-launch strategies have positioned your product for optimal reimbursement and access, a failure to execute now can equal a failed launch. Find out how to maximize product uptake. More

  • Post-Launch

    Conduct HEOR studies to uncover new evidence that will strengthen or refine your product’s clinical and economic value proposition. And forecast how policy changes, or the availability of new competitive therapies, could impact coverage and utilization by conducting research with payers and providers. More

  • Late Life Cycle

    Prepare for generic entrants by reviewing the impact of health policy on specific therapeutic areas, monitoring HTA submission requirements in emerging markets, and offering provider education programs that distinguish leading brands in a crowded marketplace. More